![]() Edwards Lifesciences Edwards Lifesciences is a provider of patient-focused medical solutions for structural heart disease and critical care monitoring. | ![]() ARTIVION CryoLife is a company engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures focused on aortic repair. | ||
Founding Date | Founding Date 2015 | Founding Date 1958 | Founding Date 1984 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations London, GB HQ Dandenong South, AU Wien, AT Markham, CA Bogotá, CO Helsinki, FI Helsinki, FI see more | Locations Irvine, US HQ Macquarie Park, AU Wien, AT Dilbeek, BE São Paulo, BR Mississauga, CA Shanghai, CN see more | Locations Kennesaw, US HQ Paris, FR Singapore, SG Guildford, GB Austin, US |
Employees | Employees 2,900 | Employees 15,80020% decrease | Employees 1,2009% increase |
Valuation ($) | Valuation ($) 2.9 b | Valuation ($) 41.8 b | Valuation ($) 1.1 b |
Financial | |||
Revenue (est.) | Revenue (est.) $1.4b (FY, 2025) | Revenue (est.) $6.1b (FY, 2025) | Revenue (est.) $441.3m (FY, 2025) |
Cost of goods | Cost of goods $448.2m (FY, 2025) | Cost of goods $1.3b (FY, 2025) | Cost of goods $157.1m (FY, 2025) |
Gross profit | Gross profit $939.9m (FY, 2025) | Gross profit $4.7b (FY, 2025) | Gross profit $284.2m (FY, 2025) |
Net income | Net income ($242.5m) (FY, 2025) | Net income $1.1b (FY, 2025) | Net income $9.8m (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 307.2m | Total funding raised $ 1.3m |

Edwards Lifesciences is a provider of patient-focused medical solutions for structural heart disease and critical care monitoring.
View company
CryoLife is a company engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures focused on aortic repair.
View company